TECH
Bio-Techne Corporation · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager): Halterbreite 0.0% · Aktienfluss +1.2% · neue Nettopositionen 0.0% — Formel
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q2 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 147 | +11 | 118.94M | $8.37B | +19 | −7 |
| Q1 2026 | 138 | +4 | 119.63M | $6.27B | +11 | −8 |
| Q4 2025 | 133 | -3 | 119.40M | $7.02B | +1 | −3 |
| Q3 2025 | 21 | +2 | 61.92M | $3.44B | +4 | −3 |
| Q2 2025 | 17 | 0 | 59.03M | $3.04B | +2 | −2 |
| Q1 2025 | 14 | +2 | 27.35M | $1.60B | +3 | −1 |
| Q4 2024 | 12 | 0 | 29.06M | $2.09B | +1 | −1 |
| Q3 2024 | 11 | +1 | 22.54M | $1.80B | +2 | −1 |
| Q2 2024 | 10 | — | 19.47M | $1.39B | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passiv) | 18.44M | — | $948.65M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (passiv) | 12.17M | — | $626.21M | 0.0% | n/c | 1 | SEC ↗ ×19 |
| 3 | T. Rowe Price ✦ | 8.85M | -22.2% | $455.23M | 0.1% | ▼ Trim | 5 | SEC ↗ ×2 |
| 4 | State Street Global Advisors ✦ (passiv) | 5.86M | -10.3% | $301.42M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passiv) | 4.06M | -0.8% | $208.62M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 6 | Citadel Advisors ✦ | 2.47M | +437.5% | $127.13M | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | Norges Bank ✦ (passiv) | 1.91M | +4.4% | $98.24M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 8 | Millennium Management ✦ | 1.64M | Neu | $84.41M | 0.1% | New | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 1.14M | -0.9% | $58.50M | 0.0% | ▼ Trim | 5 | SEC ↗ ×4 |
| 10 | Point72 Asset Management ✦ | 787.62K | +58.3% | $40.52M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 590.70K | +309.1% | $30.39M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Fidelity (FMR) ✦ | 378.02K | — | $19.45M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 13 | Arrowstreet Capital ✦ | 368.07K | +551.9% | $18.94M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Adage Capital Partners ✦ | 268.60K | -8.7% | $13.82M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 44.59K | Neu | $2.29M | 0.0% | New | 1 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 42.40K | +61.2% | $2.18M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 14.27K | +73.7% | $734,306 | 0.0% | ▲ Add | 5 | SEC ↗ ×5 |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Millennium Management | $84.41M | 0.1% |
| D. E. Shaw & Co. | $2.29M | 0.0% |
Ausgestiegen
| Marshall Wace | $51.40M | war 0.1% |
| Gotham Asset Management | $627,751 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 1 Inhaber, 426.80K Anteile, $22,304 gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.